NCT01523041View on ClinicalTrials.gov

Comparison of Two Formulations of Biphasic Insulin Aspart 70

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

November 3, 1999

Primary Completion Date

November 30, 1999

Study Completion Date

November 30, 1999

Conditions
DiabetesHealthy
Interventions
DRUG

biphasic insulin aspart 70

A single dose administrated subcutaneously (s.c., under the skin)

DRUG

biphasic insulin aspart 70

A single dose administrated subcutaneously (s.c., under the skin)

DRUG

biphasic insulin aspart 50

A single dose administrated subcutaneously (s.c., under the skin)

Trial Locations (1)

LS2 9NG

Novo Nordisk Investigational Site, Leeds

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY